Introduction
Mutations in the skeletal muscle ryanodine receptor (RYR1) gene are associated with a wide spectrum of inherited myopathies presenting throughout life [1] , including dominantly inherited Central Core Disease (CCD) [2] , and subgroups of recessively inherited Multi-minicore Disease (MmD) [3] , Centronuclear Myopathy (CNM) [4] and Congenital Fibre Type Disproportion (CFTD) [5] . The dominantly inherited Malignant Hyperthermia Susceptibility (MHS) trait, a pharmacogenetic predisposition to severe and potentially life-threatening reactions in response to volatile anaesthetics and succinylcholine (for review, [6] ), is an allelic condition; some patients with CCD may also be MH-susceptible, and MH-susceptible individuals may feature cores on muscle biopsy even without being weak.
The majority of MH-susceptible individuals are clinically asymptomatic unless exposed to triggering agents, however, several permanent or induced muscular manifestations appear to be specifically associated with MHS-related RYR1 mutations: King-Denborough syndrome (KDS) is an early-onset myopathy with short stature, scoliosis, dysmorphic features and a predisposition to MH reactions [7] .
More recently, (MHS-related) RYR1 mutations have also emerged as a common cause of exertional rhabdomyolysis (ERM), accounting for up to 30% of rhabdomyolysis (RM) episodes in otherwise healthy individuals [8] . This review will focus on the features of RYR1-related (E)RM by discussing the key features from cases reported to date, summarizing the proposed pathophysiological mechanism(s) extrapolated from observations in relevant animal models, and suggesting how this probably not uncommon manifestation of RYR1 mutations can be recognized and how it should be managed.
(Exertional) rhabdomyolysis
RM (from the Greek, literally the "dissolution of striated muscle") is the general term for muscle breakdown associated with a wide variety of external triggers, including strenuous exercise beyond the limit of fatigue, inadequate hydration, high ambient temperatures, use of supplements (ephedra, creatine, and herbal weight loss supplements) or certain medications (statins, selective serotonin reuptake inhibitors), illicit drug or alcohol abuse, muscle trauma, or recent viral illnesses. Although there is no universally accepted definition, RM is often defined as a clinical syndrome associated with severe muscle pain, sudden elevation and subsequent fall of serum creatine phosphokinase (CPK) levels with or without myoglobinuria. There is no consensus concerning the exact level of CPK rise required to fulfil the definition of RM, with suggested CPK levels ranging from > 5, > 10, > 20 to even > 50 times the upper limit of normal (ULN) [9] . ERM is defined as RM preceded by triggering strenuous exercise (often under environmental conditions at the extremes of the temperature scale).
RM results in the entry of skeletal muscle contents, in particular CPK and myoglobin, into the systemic circulation. The course is mostly characterized by myalgia with mild to moderate CPK increases, mild asymptomatic pigmenturia, and will often not even come to medical attention.
However, in a minority of patients the clinical course is severe, resulting in profound hyperCKaemia, acute renal failure, compartment syndrome, disseminated intravascular coagulation, cardiac arrhythmias secondary to electrolyte imbalances, and even cardiac arrest if left untreated. The degree of metabolic disturbances and the severity of RM-related clinical features depends on the amount of muscle damaged and various endogenous and exogenous factors (such as hypovolemia, hypotension, body temperature, sepsis, intake of toxic drugs, general health, hormone environment and genetic susceptibility). Irrespective of its cause, the pathophysiological events in RM follow a common pathway, summarized in Box 1. The annual RM prevalence has been reported as 26, 000 cases in the United States, with 47% meeting the diagnostic criteria of ERM [10] .
Box 1: Pathophysiology of exertional rhabdomyolysis (ERM)
Normally, ion pumps and channels in the sarcolemma maintain a low intracellular Na + and Ca 2+ and a high intracellular K + concentration. Unaccustomed (eccentric) exercise may cause direct injury to the sarcolemma and/or lead to failure of energy production with subsequent pump dysfunction of Na + /K + ATPase and Ca 2+ ATPase. This leads to increased cellular permeability to sodium ions and, consequently, increased intracellular calcium concentrations, with subsequent muscle contraction increasing the energy deficit. This also enhances the activation of calcium-dependent proteases and phospholipases, which contributes to destruction of myofibrillar, cytoskeletal and membrane proteins. Subsequently, large quantities of intracellular electrolytes, metabolites as well as intracellular proteins (aldolase, myoglobin, CK, lactate dehydrogenase, aspartate transaminase) leak into the circulation. The resulting free calcium will add to the contraction of the already overactivated myocytes. Electrolyte disturbances normally occurring during exercise, e.g. hypokalemia (through perspiration) and hyponatremia (due to polydipsia) reinforce this process. Potassium release from muscle cells during exercise normally mediates vasodilation and an appropriately increased muscle blood supply. Hence, hypokalemia may promote the development of RM by decreasing blood flow to muscles in response to exertion, thus limiting availability of energy sources. Next, potassium leak from myocytes into the bloodstream causes hyperkalemia, which can result in fatal cardiac arrhythmias. Hyponatremia contributes to Na + /Ca 2+ -ATPase dysfunction, which leads to the activation of proteases and lipases that are responsible for further cell lysis. Furthermore, hyponatremia causes failure of cell volume regulation. Combined with other cellular responses to exercise such as increased oxidative stress and release of pro-inflammatory cytokines, this will ultimately result in cell death and intracellular components spilling into the surrounding tissue. This is perpetuated by extreme ambient temperatures. The prolonged exposure to very low temperature causes vasoconstriction and subsequent cell damage. On the other hand, hyperthermia is considered as a hypermetabolic condition that triggers RM when the energy supplies are not adequate in relation to cellular requirements.
RM often represents a "physiological" response to extreme external triggers, such as fasting, viral infections, toxins or medication, strenuous physical exercise, exercise under extreme circumstances, or a combination of these factors [11] . In contrast, ERM might also be the first manifestation of a genetic muscle disorder, reflective of the potential of such conditions to lower the trigger threshold for developing muscle breakdown. A genetic cause should always be considered in case of recurrent, familial or paediatric episodes of ERM presenting very early in life; if such episodes are associated with other (exercise-induced) muscle symptoms such as cramps, myalgia, exercise intolerance, hyperCKemia in the personal or family history, or if the severity of RM exceeds the expected response to the exercise. The recognition of a patient with an underlying genetic disorder is essential for the acute management but also (and most importantly) for counselling afterwards. Several genetic disorders increase the risk of developing RM. These include metabolic myopathies, disorders of calcium homeostasis, various muscular dystrophies (particular limb girdle muscular dystrophies such as LGMD2I and milder dystrophinopathies), and the sickle cell trait. We refer to recent detailed reviews for an overview of genetic disorders to be considered where the nature of the RM episodes raises the suspicion of such a condition [12] [13] [14] .
RYR1-related (exertional) rhabdomyolysis ((E)RM)
A link between ERM and MHS had been suggested since the original description of the latter but until recently had only been documented in case reports and small series. Such a link is plausible, considering 1) an uncontrolled rise in intracellular skeletal muscle calcium as the most important shared pathomechanism [15] ; and 2) the common occurrence of MH and ERM in a number of porcine [16] , equine [17] and murine [18, 19] [20] . Three of these patients had RYR1
mutations but only hot-spots sequencing had been performed at the time [20] . Based on their findings, the authors recommend performing genetic testing for MH-associated RYR1 mutations, muscle biopsies for histological examination and IVCT in patients presenting with ERM. In 2009, Sambuughin sequenced the RYR1 gene in six unrelated African-American men with unexplained ERM, who were subsequently diagnosed as MHS on CHCT. Three novel mutations and two variants previously reported in Caucasian MH-Susceptible subjects were found in five patients studied, further emphasizing the importance of performing CHCT and RYR1 mutation screening in patients with unexplained ERM [21] . In our seminal study systematically investigating a possible link between ERM and RYR1 mutations in 2013, RYR1 was sequenced in 39 unrelated families with RM, in whom common metabolic and mitochondrial causes had been excluded [8] . In this series we identified nine heterozygous RYR1 mutations/variants in 14 families, five of them (K1393R; G434R;
T4288_A4290dup; A4295V; and R4737Q) previously associated with MH. Index cases presented from 3 to 45 years with RM with or without exertional myalgia (n=12) or isolated exertional myalgia (n=2).
Familial RYR1 mutations were confirmed in relatives with similar, exertional myalgia without RM, or no symptoms. We performed a systematic literature review (including the patients in the studies mentioned above), based on a Pubmed search with "RYR1" and "rhabdomyolysis". This resulted in identification of several case report and small series [1, 8, [21] [22] [23] [24] [25] [26] , and two review article [27, 28] Subsequently, we also included cases from references of these articles [20, 26, [29] [30] [31] [32] [33] [34] and added our recent letter by Snoeck et al. [35] . Finally, we added two patients from our paper on the spectrum of RYR1 related myopathies by Snoeck et al. who were not included in any other publication (patients 14 and 52 [1] ).
We excluded the patients who suffered only from exertional myalgia without clinical or biochemical RM (Family 11 and 14 in Dlamini et al. [8] ). We identified 37 patients with non-anaesthetic RM due to RYR1 mutation(s) (age range 1 -64 years; 31 males and 6 females). The most important features from these cases are summarized in Table 1 , and an illustrative case reported recently is presented in more detail in Box 2 [35] .
Box 2: RYR1-related exertional rhabdomyolysis (ERM) in a 16-year old patient -case study
This patient is a currently 21-year-old semi-professional male cyclist who has experienced three episodes of RM after cycling [35] . The first episode occurred at the age of 14, when he developed profound myalgia in his legs four days after a race, resulting in impaired walking. He recovered within one week and continued with cycling training without seeking medical advice. When he had the same symptoms two years later, his CPK was found to be elevated at 29,914 IU/l and he was admitted to the ICU for rehydration. He was referred at the age of 17. He reported that the race where the ERM episode occurred had taken place in very cold weather, but that he had competed under similar conditions before. Most likely, the combination of several triggers (use of NSAIDs because of mild flu-like symptoms before the race; very cold temperature; strenuous training preceding the race; and use of a caffeine gel as an energy booster) had caused the ERM episode after this particular race. Physical examination revealed an athletic build but mild weakness of the rhomboid muscle (MRC 4)( Figure 3 ). He also had mild bilateral ptosis. The muscle biopsy (including EM) showed an increase of internal nuclei but no cores. RYR1 sequencing revealed compound heterozygous RYR1 mutations, I2321V (maternal allel) and V4849I (paternal allel) previously associated with MH. The IVCT was positive, confirming MHS. After he was diagnosed with RYR1-related ERM, he adapted his training regime and refrained from use of caffeine and NSAIDs. Nevertheless, at the age of 18 he experienced a third ERM episode with severe myalgia and significant hyperCKaemia (10,820 IU/l), and he subsequently gave up semi-professional cycling. His father carried the G14545A mutation and was also very athletic but never experienced similar problems. However, his paternal uncle (G14545A carrier) had visited our centre at the age of 37 because of hyperCKemia, fatigue and muscle cramps. He was also very athletic (regular cycling, rugby) and had experienced exertional myalgia and muscle stiffness since the age of 35. CPK levels were around 800 IU/l. The muscle biopsy had shown mild non-specfic myopathic features (increase in fibre size variability and internal nuclei but no cores). Physical examination at the age of 49 showed an athletic build, no muscle weakness but a mild ptosis ( Figure 3 ). After genetic testing confirmed the G14545A mutation, he was counselled for the MHS risk and referred to the rehabilitation specialist for training advice. All first degree relatives were screened for the G14545 mutation because of the MHS risk.
The review of these cases revealed very important insights into the characteristic features of RYR1-related RM. First, RM manifested at all ages, with a fatal non-anaesthetic MH reactions in six children. There was a male predominance (84%). In many cases, RM was not provoked by the first exposition to a specific trigger and often a combination of variable triggers (including recreational and medical drugs) was present, both in children and adults, e.g. physical exercise and hot ambient temperatures, or viral infection or exercise and medication. Gener et al. reported the case of a child who had suffered a sevoflurane-triggered MH episode treated with dantrolene during an orchidopexy procedure (at the age of 3 years 5 months), a common operation during which MH episodes have been observed [32] . He died at the age of 5 and a half years when he developed muscle rigidity and became hyperthermic and asystolic after receiving ondansetron because of vomiting and abdominal pain [32] . A recent case published by Russell et al. illustrates a similar point:
a 20-year-old woman who developed RM, disseminated intravascular coagulopathy and multi-organ failure induced by MDMA. Following initial improvement, she developed delayed RM due to haloperidol-induced neuroleptic malignant syndrome (NMS), which was treated with dantrolene.
Subsequent genetic testing revealed a novel potentially pathogenic variant in RYR1 (G2545A). The case reported by Lavezzi showed how succinylcholine augmented the hypermetabolic state resulting from heat stroke, leading to subsequent death [33] . Furthermore, Forrest reported an MH event preceded by unaccustomed exercise, suggesting that MH may in fact also be a multifactorial event and providing a potential explanation for its highly variable penetrance [36] .
These observations support the suspected relationship between exertional heat illnesses, ERM, and MHS (Box 3) [15, 25] , with a fatal course especially in children illustrated in several reports. Nishio et al. presented a young patient (2 years 9 months) that died of heat stroke after being left in a car in high environmental temperature. Postmortem mutation analysis revealed that the child carried compound heterozygous RYR1 mutations L4320_R4322dup and R4645Q. Since each mutation had previously been documented to cause MHS on its own, a non-anaesthetic MH-like response prompted by high environmental high temperature might have occurred in this child essentially carrying a "double-dose" of MHS-related RYR1 mutations [30] . Groom et al. reported a de novo RYR1 variant (R3983C) in two unrelated children who experienced fatal, non-anesthetic MH episodes associated with febrile illness and heat stress. One of those children had numerous episodes of leg cramping, tachycardia, tachypnea and increased creatinine kinase years before the fatal episode [29] .
Tobin reported a 13-year old patient who died of a stress-induced hyperpyrexic death without anaesthetic exposure after a football game with an ambient temperature of 26°C. One and a half year prior, he had developed an MH response to general anaesthesia, for which he was successfully treated with dantrolene. Post mortem RYR1 sequencing revealed a RYR1 mutation (R163C) in the patient and, on further testing, in his father [31] . The children reported by Gener and Lavezzi also had a fatal outcome of their heat illness. [32, 33] This clinical overlap has implications for some MHsusceptible patients and their capacity to exercise, as well as for clinicians treating and anesthetizing patients with histories of unexplained exertional heat and exercise illnesses [25] . [15, 25, 37] Exertional heat illness, ERM, and MH have similar pathophysiology: all three are hypermetabolic states that include high demand for adenosine triphosphate, accelerated oxidative, chemical, and mechanical stress of muscle, and uncontrolled increase in intracellular calcium.
Box 3: Exertional heat illness, exertional rhabdomyolysis (ERM), and malignant hyperthermia susceptibility (MHS)
Heat related illnesses: 1. Heat stroke: a severe condition of hyperthermia (body temperature > 40.6 °C (105.1 °F)) due to environmental heat exposure with lack of thermoregulation. The term "stroke" in "heat stroke" refers to the altered mental status that accompanies this hypermetabolic condition. Prevention consists of drinking plenty of cool liquids and avoiding excessive heat and humidity, especially in unventilated spaces. Treatment requires rapid physical cooling of the body. 2. Heat exhaustion: a condition of heavy sweating and tachycardia, resulting in dehydration, salt-depletion, and hypovolaemia. Causes include exposure to high temperatures, particularly when combined with high humidity, and strenuous physical activity. Without prompt treatment, heat exhaustion can lead to heatstroke. 3. Heat syncope: fainting due to peripheral vasodilatation secondary to high ambient temperature. It occurs with or without mental confusion.
Heat cramps:
Painful, brief muscle cramps that occur during exercise or work in a hot environment or begin a few hours later. They are likely to be related to electrolyte problems due to extensive sweating and rehydration with large amounts of water or other fluids that lack salt.
Exertional rhabdomyolysis (ERM): the breakdown of muscle from extreme physical exertion. It is a common complication of exertional heat illness, but may also occur in the absence of features of exertional heat illness. There is a clear association with RYR1 variants, including variants associated with MH susceptibility. Risk factors: strenuous exercise under high temperatures and humidity; poor hydration; inadequate recovery between exercise, inadequate fitness levels.
Malignant hyperthermia (MH):
a rare life-threatening condition that is characterized by rapid rise of end-tidal CO 2 and body temperature occuring in susceptible individuals who receive volatile anesthetic agents and/or succinylcholine. In susceptible individuals, these drugs can induce a drastic and uncontrolled increase in oxidative metabolism as a result of a persistent intracellular Ca 2+ , which devastate the capacity to supply oxygen, remove carbon dioxide, and regulate body temperature, eventually leading to circulatory collapse and death if not immediately treated.
These latter cases also point to the muscular symptoms that were present prior to the RM episode in many of the index cases. More than half of the patients we identified through our literature search reported prior exertional myalgia ( Table 1) . Two of the three families reported by Davis et al. also
reported intermittent muscle pain and cramps, often precipitated by exercise. These episodes lasted for two weeks and were so severe that walking was impaired [26] . Finally, muscle biopsy showed signs of a congenital myopathy in only one patient and one carrier father; all other biopsies were normal or showed only aspecific changes. The case reported by Capacchione et al. illustrates that symptoms increase in the course of several days after the strenuous exercise [25] . This was also reported by the young cyclist in Box 2: in both episodes, the myalgia manifested three to four days after the race. This timeline is similar to the development of myalgia after unaccustomed exercise in healthy individuals, and parallels the CPK increase ( Figure 2 ). Heat-induced RM generally develops more rapidly, which likely results from acidbase and plasma composition changes. The initial lactic acidosis and respiratory alkalosis evolves into a predominantly metabolic acidosis, reflecting tissue damage (release of sulphate, phosphate and organic acids).
Finally, individuals with RYR1-related RM are often particularly muscular and athletic, making life style advice after a RM event more challenging. One of the patients reported by Dlamini et al.
(patient 7.II.2;also patient 23 in Snoeck et al.) had to change her plans to become a sports coach after the second ERM episode with CPK levels up to 378,900 IU/l [1, 8] . Similarly, the patient illustrated above (Box 1) stopped cycling semi-professionally only after another episode of RM requiring hospital admission occurred a year after he was diagnosed with RYR1-related RM.
As a complicating factor, counselling might be challenging in cases with more than one RYR1 mutation, especially where the pathogenicity of individual mutations is not defined yet. In the cohort we identified, nine patients had more than one mutation (Table 1) . Another complicating factor in counselling is the often highly variable penetrance of the familial RYR1 mutation. The father of the patient in box 2 also carried the RYR1 mutation and was very active in sports, but never experienced any RM episodes. [35] Even more remarkable is the carrier brother of patient 7.II.2 reported in Dlamini et al. (Figure 1 in that article), who is very active in weightlifting competition but never had any RM episodes [8] .
A particular complex issue is the variable relationship between RYR1-related RM and the results of CHCT or IVCT testing. validated by comparing muscle biopsy tissue from patients with documented histories of anesthesiarelated MH to muscle biopsy tissue from control patients resulting in a specificity of 93,6% and a sensitivity of 99% [38] . As a result, using the CHCT or IVCT to diagnose people as MHS who present with (E)RM, given that these tests were not developed or validated to evaluate these patients, might
give false-positive results. In the three patients with negative tests, pathogenicity was assumed based on the presence of biallellic mutations (patient 52), the absence of the mutation in normal population, and/or the results of in silico analysis. Functional testing of the mutant RyR1 channels in a suitable expression system will be required to confirm the pathogenicity of mutations where CHCT or IVCT testing is equivocal or negative.
The case reported by Lavezzi et al illustrates the importance of recognizing RYR1-related heat illness: this healthy 6-year-old boy developed lower extremity rigidity, trismus, and fever after playing in an inflatable swimming pool. On arrival in the emergency department, he appeared to be
seizing. An endotracheal tube was urgently placed using succinylcholine to facilitate muscle relaxation, he went into cardiac arrest and resuscitation attempts were unsuccessful. Post mortem genetic analysis showed a novel RYR1 variant, also confirmed in his father who had a positive CHCT response and central cores on the muscle biopsy [33] . This case, and that of Capacchione [25] exemplify that (E)RM is a presentation of RYR1-related myopathies most anaesthesiologists are not familiar with [25, 33] . Furthermore, most general practitioners, emergency department physicians, hospital doctors, and intensivists do not associate (E)RM with MH; thus, consideration of RYR1 mutations as a cause may be easily forgotten. Although the incidence of fulminant MH during anaesthesia is relatively rare (with estimates between 1 in 4200 to 250,000), the incidence of RYR1 mutations with MHS in the general population might be up to 1 in 2000 [5] . This implies that there is a cohort of possible MH-Susceptible individuals who do never develop MH during general anaesthesia but may well present with ERM at one point in life. In support of this point, exome sequencing performed on 870 volunteers without medical or family histories for MHS identified three RYR1 variants predicted to predispose to MH reactions. [39] Finally, the case reported by Potts et al illustrate the continuous use of dantrolene for treatment of cramps and prevention of RM: these 30-year-old identical twin brothers with persistent hyperCKemia, severe debilitating muscle cramps, and unexplained RM both required oral dantrolene therapy to control their symptoms [34] .
Pathophysiology. The precise pathophysiological mechanism(s) underlying human RYR1-related (E)RM are still unknown but investigations in relevant animal models may provide useful information: studies in the Y522S RyR1 KI mouse (a murine model of human MH) suffering RM and death in response to elevated environmental temperatures suggest a complex interplay and a vicious cycle involving the primary RyR1 defect and secondary metabolic RyR1 modifications: The murine Y522S
RyR1 was shown to cause a Ca 2+ leak, which drives increased generation of reactive nitrogen species; the resulting S-nitrosylation of the mutant RyR1 receptor in turn further increases its temperature sensitivity, lowering the threshold for producing muscle contractures upon exposure to elevated temperatures. Many mitochondria in the muscle of heterozygous Y522S mice are swollen and misshapen, and the mutants display force reduction with aging. Assuming that mitochondria as a store of Ca2+ play a buffering role in controlling cytosolic Ca2+ metabolism under normal conditions, the authors propose a destructive feed-forward cyclic mechanism that increases the temperature sensitivity of RyR1 activation and underlies heat stroke and sudden death. They propose that this cycle eventually produces a myopathy with damaged mitochondria due to defects of the mitochondrial respiratory chain (Figure 4 ) [19] . The overall increase in RyR1 sensitivity to activation by stimuli that promote Ca 2+ release render the muscle more susceptible to rhabdomyolysis to the presence of any trigger, among which is (eccentric) strenuous exercise.
[18]
Management
Acute management. The first step when encountering a patient with a (E)RMis to determine whether the RM is clinically significant, requiring hospital admission and intravenous fluid administration.
Although randomized controlled trials offering concrete management guidelines for these aspects of RM management do not exist, the study by Kenney at al. reporting a large cohort of representative cases with physiological ERM offers some practical guidelines at least for the initial steps (summarized in Box 4 and [9] ). The goals of both inpatient and/or outpatient treatment are to avoid renal injury, prevent further muscle injury, and to limit complications resulting from electrolyte disturbances; this is summarized in Box 5. Most importantly, in RYR1-related ERM cases, the specific RyR1 antagonist dantrolene can be administered to limit further muscle breakdown and CPK increases, and more severe, potentially life-threatening downstream medical complications. In addition, allopurinol has recently been suggested as a treatment for exercise-induced muscle damage [40] . Allopurinol is a purine hypoxanthine-based structural analogue and a well-known inhibitor of xanthine oxidase, an enzyme which generates free radicals during oxidative stress induced by intensive muscular activity. Its administration may hence be regarded as promising, safe, and an economic strategy to decrease transient skeletal muscle damage and limit RM.  CPK < 5 x ULN and normal blood urea: no further studies  Return every 72 h and repeat until CPK < 5 x ULN and normal blood urea  CPK ≥ 5 x ULN or abnormal blood urea for > 2 weeks: refer for expert consultation  CPK ≥ 50 x ULN (10,000 U/l): refer to ER again Refrain from sports Elimination of medications, drugs and toxins that are considered to cause RM Clinical management of patients with clinically significant RM Administration of oral or iv dantrolene (dose dependent on severity of RM and hypermetabolic state) Hyperhydration: Intravenous fluids should be initiated as soon as possible, preferably within the first 6 hours after muscle injury, at a rate that maintains a urine output in adults of ≥ 300 mL/h for at least the first 24 hours Admittance to ICU Peritoneal dialysis or hemodialysis in patients with little or no urine output despite hyperhydration, profound acidosis, or severe hyperkalemia Mannitol should be administered only to maintain urine output of 300 mL/h or more despite adequate fluid administration Sodium bicarbonate should be administered only if necessary to correct systemic acidosis Elimination of medications, drugs and toxins that are considered to cause RM Low dose oral dantrolene could also be considered for the treatment of chronic muscle pain and prevention of recurrent episodes in individuals with MHS or RYR1-related RM without significantly affecting performance [44] .
Box 4: Features requiring hospital admission and intravenous fluid administration
Restarting sports. Patients with RYR1-related ERM will have a higher recurrence risk and will have to episode. Myoglobin is the first enzyme that increases, but returns to normal levels within the first 24 hours after onset of symptoms. CPK increases a few hours later, reaches its peak value within the first 24 hours, and remains at these levels for around 3 days. Even though the presence of myoglobin in serum is the key feature of RM, CPK is considered to be a more useful marker for the diagnosis and assessment of the severity of muscle injury due to its delayed plasma clearance and the wider availability for diagnostic testing.
[ Table 1 Sex: m = male; f = female Race: A = African; AA = African-American; C = Caucasian; AC = Afro-Caribbean Mutation(s): amino acid changes unless otherwhise specified Triggers: E = exercise; H = heat; I = infection; D = drugs; 1 MDMA, haloperidol; 2 simvastatin; 3 alcohol; 4 caffeine gel; 5 olanzapine; 6 succinylcholine CHCT: caffeine halothane contraction test / IVCT: in vitro contracture test (in patient or in one of the related RYR1 mutation carriers; ND: not determined (mostly in cases in which previously reported mutations were detected) Muscle biopsy: MmD = Multi-minicore Disease; CCD = Central Core Disease; OS = oxidative staining
